Belgium· BE-AMP-SAM506453-00
Feraccru 30 mg
A ferric maltol product containing ferric maltol, registered in Belgium by Norgine. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ferric maltol is registered in 12 of 19 countries.
Countries holding a registration under ATC B03AB10 (ferric maltol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Ferric maltol · ATC B03AB10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ferric Maltol
- Manufacturer
- Norgine
- Country
- Belgium (BE)
- ATC code
- B03AB10
- ATC class
- Ferric maltol
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4160503
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ferric maltol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFERACCRUNorgine B.V., Amsterdam
- SpainFERACCRU 30 MG CAPSULAS DURASNorgine B.V.
- FinlandFeraccruNorgine B.V.
- United KingdomFeraccru 30mg capsulesNorgine Pharmaceuticals Ltd
- IrelandFeraccru 30 mg hard capsulesNorgine B.V.
- IcelandFeraccruNorgine B.V.
- NorwayFeraccruNorgine B.V.
- SwedenFeraccru 30 mg Kapsel, hårdNorgine BV
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Feraccru
- Iceland · Feraccru
- Liechtenstein · Feraccru
- Norway · Feraccru
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/57244c18-8df1-4edc-a3ce-23ce508593ed GET /v1/drugs/57244c18-8df1-4edc-a3ce-23ce508593ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Feraccru 30 mg",
"name_fr": "Feraccru 30 mg",
"name_nl": "Feraccru 30 mg",
"amp_code": "SAM506453-00",
"strengths": [
"30.0000",
"30.0000",
"0.1000",
"0.1000",
"91.5000",
"91.5000",
"0.3000"
],
"pack_count": 4,
"substances": [
"Ferric Maltol",
"Iron",
"E 110",
"Lactose Monohydrate",
"Propylene Glycol",
"Sodium Laurilsulfate",
"E 129"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ferric Maltol",
"authorisation_numbers": [
"EU/1/15/1075/001",
"EU/1/15/1075/002",
"EU/1/15/1075/003",
"EU/1/15/1075/004"
]
}See everything about ferric maltol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.